Legend Biotech Corp ADR

3 wrz 2026, 19:47 UTC

Shares of Legend Biotech Corp are lower today, despite earlier fluctuations that reached a session high. The stock remains above its 20-day moving average.

2 wrz 2026, 20:03 UTC

Legend Biotech shares are higher as management discusses CARVYKTI's commercial rollout and plans to expand manufacturing capabilities at the Morgan Stanley Global Healthcare Conference.

1 wrz 2026, 20:01 UTC

Legend Biotech will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2026, as shares trade higher since Monday's close.

31 sie 2026, 22:16 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting a shift from recent higher daily closes amid broader market reactions to inflation comments from the Fed.

28 sie 2026, 20:07 UTC

Legend Biotech Corp shares are lower today, marking a fourth consecutive decline. Rising U.S. Treasury yields may be impacting investor sentiment.

27 sie 2026, 22:26 UTC

Legend Biotech Corp. shares are higher in after-market trading, gaining slightly since Thursday's close amid routine market fluctuations.

26 sie 2026, 23:11 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting the broader market's upward trend amid positive sentiment from major stocks.

25 sie 2026, 19:06 UTC

Shares of Legend Biotech Corp are higher today, remaining above their 20-day moving average amid positive market sentiment linked to falling oil prices.

24 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 sie 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 sie 2026, 20:03 UTC

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 sie 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 sie 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 sie 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 sie 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 sie 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 sie 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 sie 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 sie 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 sie 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 lip 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

30 lip 2026, 22:41 UTC

Shares of Legend Biotech Corp are trading lower in after-market hours, continuing a trend of unusual weakness since Thursday's close.

29 lip 2026, 19:27 UTC

Legend Biotech Corp shares are lower, extending a four-session decline. Raymond James projects a 12-month price target range of $58 to $86.

28 lip 2026, 22:56 UTC

Shares of Legend Biotech Corp are trading higher in after-market hours, despite no specific news identified. The broader market showed gains earlier in the day.

27 lip 2026, 23:16 UTC

Legend Biotech Corp shares are higher in after-market hours, having briefly reached a session high. The price remains below its 20-day moving average.

24 lip 2026, 19:16 UTC

UBS downgraded Legend Biotech Corp to Neutral and cut its price target to $28, contributing to a decline in shares during Friday's session.

22 lip 2026, 18:31 UTC

Legend Biotech Corp shares are lower today amid broader market weakness and rising geopolitical tensions, despite an earlier peak during the session.

21 lip 2026, 16:46 UTC

Legend Biotech Corp. shares are higher today, reaching a session peak amid rising crude oil prices, despite trading below its 20-day moving average.